NCT00424398View on ClinicalTrials.gov

Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2007

Conditions

Conjunctivitis, Allergic

Interventions

DRUG

Bepreve

sterile ophthalmic solution

DRUG

Placebo

sterile ophthalmic solution

DRUG

Bepotastine Besilate

sterile ophthalmic solution

Trial Locations (1)

92630

ISTA Pharmaceuticals, Inc., Irvine

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00424398 - Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter